| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 565 | 2020 |
| A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition ME Dieterle, D Haslwanter, RH Bortz, AS Wirchnianski, G Lasso, ... Cell host & microbe 28 (3), 486-496. e6, 2020 | 206 | 2020 |
| Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection AZ Wec, ZA Bornholdt, S He, AS Herbert, E Goodwin, AS Wirchnianski, ... Cell host & microbe 25 (1), 39-48. e5, 2019 | 97 | 2019 |
| Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... ACS omega 6 (1), 85-102, 2020 | 85 | 2020 |
| Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial MB Ortigoza, H Yoon, KS Goldfeld, AB Troxel, JP Daily, Y Wu, Y Li, D Wu, ... JAMA internal medicine 182 (2), 115-126, 2022 | 75 | 2022 |
| Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC H ah Yoon, R Bartash, I Gendlina, J Rivera, A Nakouzi, RH Bortz III, ... JCI insight 6 (4), 2021 | 50* | 2021 |
| A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’brien, M Sakharkar, C Florez, ... Mbio 12 (5), 10.1128/mbio. 02473-21, 2021 | 44* | 2021 |
| Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response JD Herman, C Wang, C Loos, H Yoon, J Rivera, M Eugenia Dieterle, ... Nature communications 12 (1), 6853, 2021 | 29 | 2021 |
| Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes G Lasso, S Khan, SA Allen, M Mariano, C Florez, EP Orner, JA Quiroz, ... PLOS Computational Biology 18 (1), e1009778, 2022 | 15 | 2022 |
| A hyperstabilizing mutation in the base of the Ebola virus glycoprotein acts at multiple steps to abrogate viral entry JM Fels, JS Spence, RH Bortz III, ZA Bornholdt, K Chandran MBio 10 (4), 10.1128/mbio. 01408-19, 2019 | 12 | 2019 |
| A virion-based assay for glycoprotein thermostability reveals key determinants of filovirus entry and its inhibition RH Bortz III, AC Wong, MG Grodus, HS Recht, MC Pulanco, G Lasso, ... Journal of virology 94 (18), 10.1128/jvi. 00336-20, 2020 | 10 | 2020 |
| A glycoprotein mutation that emerged during the 2013–2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion JM Fels, RH Bortz III, T Alkutkar, E Mittler, RK Jangra, JS Spence, ... Mbio 12 (1), 10.1128/mbio. 03616-20, 2021 | 9 | 2021 |
| Single-dilution COVID-19 antibody test with qualitative and quantitative readouts RH Bortz III, C Florez, E Laudermilch, AS Wirchnianski, G Lasso, ... Msphere 6 (2), 10.1128/msphere. 00224-21, 2021 | 7 | 2021 |
| Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts RH Bortz III, C Florez, E Laudermilch, AS Wirchnianski, G Lasso, ... medRxiv, 2020 | 7 | 2020 |
| Approaching the interpretation of discordances in SARS-CoV-2 testing SN Wontakal, RH Bortz III, WHW Lin, I Gendlina, AS Fox, EA Hod, ... Open Forum Infectious Diseases, 2021 | 3 | 2021 |
| Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference JM Fels, S Khan, R Forster, KA Skalina, S Sirichand, AS Fox, A Bergman, ... Molecular Case Studies 8 (5), a006211, 2022 | 2* | 2022 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays: The Value of Numeric Reporting SK Forest, EP Orner, DY Goldstein, AS Wirchnianski, RH Bortz III, ... Archives of Pathology & Laboratory Medicine 145 (8), 929-936, 2021 | 1 | 2021 |
| Antiviral Therapeutics Exploit Entry-Related Structural Changes in the Ebola Virus Glycoprotein RH Bortz III Albert Einstein College of Medicine, 2021 | | 2021 |
| A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition (preprint) ME Dieterle, D Haslwanter, RH Bortz III, AS Wirchnianski, G Lasso, ... | | 2020 |
Kartik ChandranAlbert Einstein College of Medicine在 einsteinmed.edu 的电子邮件经过验证
